The journal
Open the journal →The conversation starts in the journal — be the first to post.
About abacavir/lamivudine/zidovudine
Abacavir/lamivudine/zidovudine, sold under the brand name Trizivir, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS. It contains three reverse transcriptase inhibitors patented by GlaxoSmithKline and marketed by a joint venture with Pfizer, ViiV Healthcare:abacavir sulfate (ABC)
Everything about abacavir/lamivudine/zidovudine →